Personalizing medicine for autoimmune and inflammatory diseases

被引:29
作者
Chan, Andrew C. [1 ]
Behrens, Timothy W. [1 ]
机构
[1] Genentech Inc, San Francisco, CA 94080 USA
关键词
MONOCLONAL-ANTIBODY; INTERFERON; ALPHA;
D O I
10.1038/ni.2473
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Therapies that target molecular pathways do not provide uniform benefits for all patients at present. New transformative therapies for autoimmune and inflammatory diseases require greater molecular understanding of patient subsets and the ability to personalize targeted therapies for each subset.
引用
收藏
页码:106 / 109
页数:4
相关论文
共 19 条
[1]   Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer [J].
Amado, Rafael G. ;
Wolf, Michael ;
Peeters, Marc ;
Van Cutsem, Eric ;
Siena, Salvatore ;
Freeman, Daniel J. ;
Juan, Todd ;
Sikorski, Robert ;
Suggs, Sid ;
Radinsky, Robert ;
Patterson, Scott D. ;
Chang, David D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1626-1634
[2]   Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus [J].
Baechler, EC ;
Batliwalla, FM ;
Karypis, G ;
Gaffney, PM ;
Ortmann, WA ;
Espe, KJ ;
Shark, KB ;
Grande, WJ ;
Hughes, KM ;
Kapur, V ;
Gregersen, PK ;
Behrens, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) :2610-2615
[3]   Interferon and granulopoiesis signatures in systemic lupus erythematosus blood [J].
Bennett, L ;
Palucka, AK ;
Arce, E ;
Cantrell, V ;
Borvak, J ;
Banchereau, J ;
Pascual, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (06) :711-723
[4]   Glivec (ST1571, Imatinib), a rationally developed, targeted anticancer drug [J].
Capdeville, R ;
Buchdunger, E ;
Zimmermann, J ;
Matter, A .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (07) :493-502
[5]   Lebrikizumab Treatment in Adults with Asthma [J].
Corren, Jonathan ;
Lemanske, Robert F., Jr. ;
Hanania, Nicola A. ;
Korenblat, Phillip E. ;
Parsey, Merdad V. ;
Arron, Joseph R. ;
Harris, Jeffrey M. ;
Scheerens, Heleen ;
Wu, Lawren C. ;
Su, Zheng ;
Mosesova, Sofia ;
Eisner, Mark D. ;
Bohen, Sean P. ;
Matthews, John G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (12) :1088-1098
[6]   A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus [J].
Furie, Richard ;
Petri, Michelle ;
Zamani, Omid ;
Cervera, Ricard ;
Wallace, Daniel J. ;
Tegzova, Dana ;
Sanchez-Guerrero, Jorge ;
Schwarting, Andreas ;
Merrill, Joan T. ;
Chatham, W. Winn ;
Stohl, William ;
Ginzler, Ellen M. ;
Hough, Douglas R. ;
Zhong, Z. John ;
Freimuth, William ;
van Vollenhoven, Ronald F. .
ARTHRITIS AND RHEUMATISM, 2011, 63 (12) :3918-3930
[7]   Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial [J].
Hanauer, SB ;
Sandborn, WJ ;
Rutgeerts, P ;
Fedorak, RN ;
Lukas, M ;
Macintosh, D ;
Panaccione, R ;
Wolf, D ;
Pollack, P .
GASTROENTEROLOGY, 2006, 130 (02) :323-332
[8]   Common variants at five new loci associated with early-onset inflammatory bowel disease [J].
Imielinski, Marcin ;
Baldassano, Robert N. ;
Griffiths, Anne ;
Russell, Richard K. ;
Annese, Vito ;
Dubinsky, Marla ;
Kugathasan, Subra ;
Bradfield, Jonathan P. ;
Walters, Thomas D. ;
Sleiman, Patrick ;
Kim, Cecilia E. ;
Muise, Aleixo ;
Wang, Kai ;
Glessner, Joseph T. ;
Saeed, Shehzad ;
Zhang, Haitao ;
Frackelton, Edward C. ;
Hou, Cuiping ;
Flory, James H. ;
Otieno, George ;
Chiavacci, Rosetta M. ;
Grundmeier, Robert ;
Castro, Massimo ;
Latiano, Anna ;
Dallapiccola, Bruno ;
Stempak, Joanne ;
Abrams, Debra J. ;
Taylor, Kent ;
McGovern, Dermot ;
Heyman, Melvin B. ;
Ferry, George D. ;
Kirschner, Barbara ;
Lee, Jessica ;
Essers, Jonah ;
Grand, Richard ;
Stephens, Michael ;
Levine, Arie ;
Piccoli, David ;
Van Limbergen, Johan ;
Cucchiara, Salvatore ;
Monos, Dimitri S. ;
Guthery, Stephen L. ;
Denson, Lee ;
Wilson, David C. ;
Grant, Struan F. A. ;
Daly, Mark ;
Silverberg, Mark S. ;
Satsangi, Jack ;
Hakonarson, Hakon .
NATURE GENETICS, 2009, 41 (12) :1335-U107
[9]   Activation of the interferon-α pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease [J].
Kirou, KA ;
Lee, C ;
George, S ;
Louca, K ;
Peterson, MGE ;
Crow, MK .
ARTHRITIS AND RHEUMATISM, 2005, 52 (05) :1491-1503
[10]   A Large-Scale, Consortium-Based Genomewide Association Study of Asthma [J].
Moffatt, Miriam F. ;
Gut, Ivo G. ;
Demenais, Florence ;
Strachan, David P. ;
Bouzigon, Emmanuelle ;
Heath, Simon ;
von Mutius, Erika ;
Farrall, Martin ;
Lathrop, Mark ;
Cookson, William O. C. M. ;
Kumar, Ashish ;
Burney, Peter ;
Jarvis, Debbie ;
Wjst, Matthias ;
Kogevinas, Manolis ;
Jogi, Rain ;
Janson, Christer ;
Franklin, Karl A. ;
Omenaas, Ernst ;
Leynaert, Benedicte ;
Pin, Isabelle ;
Heinrich, Joachim ;
Probst-Hensch, Nicole M. ;
Anto, Josep M. ;
Sunyer, Jordi ;
Maldonado, Jose-Antonio ;
Martinez-Moratalla, Jesus ;
Urrutia, Isabel ;
Payo, Felix ;
Kauffmann, Francine ;
Dizier, Marie-Helene ;
Siroux, Valerie ;
Boznanski, Andrzej ;
Braun-Fahrlaender, Charlotte ;
Genuneit, Jon ;
Glas, Juergen ;
Horak, Elisabeth ;
Kabesch, Michael ;
Pillai, Sreekumar G. ;
Helms, Peter J. ;
Carlsen, Karin ;
Carlsen, Kai-Hakon ;
Gerritsen, Jorrit ;
Silverman, Michael ;
Sly, Peter ;
Tsanakas, John ;
Von Berg, Andrea ;
Whyte, Moira ;
Blumenthal, Malcolm ;
Imboden, Medea .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (13) :1211-1221